Angeles Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
20,951
+196
+0.9% +$11.4K 0.07% 108
2025
Q4
$1.12M Buy
20,755
+7,468
+56% +$359K 0.06% 129
2025
Q3
$599K Sell
13,287
-1,696
-11% -$79.2K 0.04% 163
2025
Q2
$694K Buy
14,983
+1,406
+10% +$69K 0.05% 144
2025
Q1
$828K Buy
13,577
+163
+1% +$9.5K 0.07% 103
2024
Q4
$759K Buy
13,414
+1,056
+9% +$59K 0.06% 113
2024
Q3
$639K Buy
12,358
+3,163
+34% +$148K 0.06% 120
2024
Q2
$382K Buy
9,195
+392
+4% +$17.5K 0.04% 146
2024
Q1
$477K Sell
8,803
-1,518
-15% -$77.3K 0.05% 121
2023
Q4
$530K Buy
10,321
+1,754
+20% +$92.1K 0.06% 107
2023
Q3
$497K Sell
8,567
-229
-3% -$14K 0.07% 92
2023
Q2
$563K Sell
8,796
-262
-3% -$17.6K 0.08% 104
2023
Q1
$628K Hold
9,058
0.09% 102
2022
Q4
$652K Sell
9,058
-12
-0.1% -$905 0.11% 93
2022
Q3
$645K Buy
9,070
+1,193
+15% +$86.5K 0.13% 80
2022
Q2
$607K Buy
7,877
+738
+10% +$56.2K 0.12% 89
2022
Q1
$521K Buy
+7,139
New +$479K 0.1% 105

Other funds holding BMY

Angeles Wealth Management's BMY Position: Q1 2026 in Review

Angeles Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.94% in Q1 2026, buying an estimated $11.4K and bringing the position to 20,951 shares worth $1.27M. The position accounts for 0.07% of the portfolio, ranked #108.

Angeles Wealth Management first reported a position in BMY in Q1 2022 and has held it in 17 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Angeles Wealth Management held 20,951 shares of Bristol-Myers Squibb worth $1.27M as of Q1 2026.
  • Angeles Wealth Management bought 196 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.4K.
  • Bristol-Myers Squibb made up 0.07% of Angeles Wealth Management's portfolio in Q1 2026, its #108 holding.
  • Angeles Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 17 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.